A principal component analysis of postinjury viscoelastic assays: clotting factor depletion versus fibrinolysis - Wikidata - awgldk - TriplyDB

A principal component analysis of postinjury viscoelastic assays: clotting factor depletion versus fibrinolysis

A principal component analysis of postinjury viscoelastic assays: clotting factor depletion versus fibrinolysis

http://www.wikidata.org/entity/Q34115729

about

An International Normalized Ratio-Based Definition of Acute Traumatic Coagulopathy Is Associated With Mortality, Venous Thromboembolism, and Multiple Organ Failure After Injury Taking the Blood Bank to the Field: The Design and Rationale of the Prehospital Air Medical Plasma (PAMPer) Trial Goal-directed Hemostatic Resuscitation of Trauma-induced Coagulopathy: A Pragmatic Randomized Clinical Trial Comparing a Viscoelastic Assay to Conventional Coagulation Assays Advances in the understanding of trauma-induced coagulopathy Hyperfibrinolysis, physiologic fibrinolysis, and fibrinolysis shutdown: the spectrum of postinjury fibrinolysis and relevance to antifibrinolytic therapy Plasma is the physiologic buffer of tissue plasminogen activator-mediated fibrinolysis: rationale for plasma-first resuscitation after life-threatening hemorrhage.Postinjury fibrinolysis shutdown: Rationale for selective tranexamic acid Fibrinolysis shutdown phenotype masks changes in rodent coagulation in tissue injury versus hemorrhagic shock.Overwhelming tPA release, not PAI-1 degradation, is responsible for hyperfibrinolysis in severely injured trauma patients.Acute Fibrinolysis Shutdown after Injury Occurs Frequently and Increases Mortality: A Multicenter Evaluation of 2,540 Severely Injured Patients.Clinical assessment of trauma-induced coagulopathy and its contribution to postinjury mortality: A TACTIC proposal.Tranexamic acid is associated with increased mortality in patients with physiological fibrinolysis.Overexpression of miR-24 Is Involved in the Formation of Hypocoagulation State after Severe Trauma by Inhibiting the Synthesis of Coagulation Factor X.Viscoelastic Tissue Plasminogen Activator Challenge Predicts Massive Transfusion in 15 Minutes.Management of Trauma-Induced Coagulopathy with Thrombelastography.Individual clotting factor contributions to mortality following trauma.Progresses in understanding trauma-induced coagulopathy and the underlying mechanism.[Uncritical use of tranexamic acid in trauma patients : Do no further harm!][Early viscoelasticity-based coagulation therapy for severely injured bleeding patients: Report of the consensus group on the consensus conference 2014 for formulation of S2k guidelines].Rationale for the selective administration of tranexamic acid to inhibit fibrinolysis in the severely injured patient.Targeting resuscitation to normalization of coagulating status: Hyper and hypocoagulability after severe injury are both associated with increased mortality.Goal-directed Hemostatic Resuscitation for Trauma Induced Coagulopathy : Maintaining Homeostasis.Harmful or Physiologic: Diagnosing Fibrinolysis Shutdown in a Trauma Cohort With Rotational Thromboelastometry.

P2860

Q27318121-7AB092BF-C8A6-41F5-84B8-291FE3A102F0 Q33457151-CCA2B78C-A429-4643-BBD3-730E1C01D22A Q33689210-92FBF97D-BF2A-4A45-B8BC-F0FDF12A67DF Q34677754-CCD66BCE-42F1-48A2-A43D-62EBB8691AE1 Q35207771-4B402627-28E8-4CF1-BB85-F9B067CE0350 Q35537165-55C4713C-B0FB-4D44-953C-64114EA5EDCD Q35646892-962B71B1-B153-4359-97EE-3AA927D51222 Q35822899-2A7DC007-D125-4CE3-8CC9-C2A13F884C40 Q36396010-4F585D96-BBAF-42DF-BC4B-89AFBE5548F9 Q36807586-3B25C908-1224-4B95-A805-00A3D97258E5 Q37624715-DC40A06E-12B1-4067-B8DF-1E7984179CB4 Q38653755-18BE552F-1493-430A-8D97-019CC60D824D Q38697605-A42203C8-37E8-413D-AB73-63F377F0963E Q38776292-C77D7760-2EEB-4A84-8A3D-463DFF9154B7 Q39022502-9D3AF858-A5B1-4F18-B480-A17A5A79A27D Q39139392-09F7985D-2595-43A0-B024-4D2FC8485E0C Q39336502-9FA2FC17-3FCB-43E9-B0C8-4466B19081F6 Q40577604-4B0B271A-6F48-4237-85AE-CD138B1B76BE Q41619894-63634D6D-D688-459E-98BE-FD73F706FD8A Q45375279-80F9A212-AD80-4BA8-A479-7D5558BEDA3F Q47880955-F09F024A-5AB9-42B8-87C8-56447C83C14F Q50045370-8A5BC8E2-1E16-4F8B-8C1D-CD3CC673100C Q52570198-49549299-8E60-4742-851F-6976D9F7324D

P2860

A principal component analysis of postinjury viscoelastic assays: clotting factor depletion versus fibrinolysis

http://www.wikidata.org/entity/Q34115729

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

A principal component analysis ...... depletion versus fibrinolysis

@ast

A principal component analysis ...... depletion versus fibrinolysis

@en

A principal component analysis ...... depletion versus fibrinolysis

@nl

type

label

A principal component analysis ...... depletion versus fibrinolysis

@ast

A principal component analysis ...... depletion versus fibrinolysis

@en

A principal component analysis ...... depletion versus fibrinolysis

@nl

prefLabel

A principal component analysis ...... depletion versus fibrinolysis

@ast

A principal component analysis ...... depletion versus fibrinolysis

@en

A principal component analysis ...... depletion versus fibrinolysis

@nl

P1433

Q34115729-29C00520-AD2E-4CE6-82A5-5FFA1F47ED31

P1476

Q34115729-C4E2E6EF-C0FE-4845-AB9E-B0D43D47249C

P2093

Q34115729-0DB28236-E7E7-4D4A-80EC-6F9368C4E905

Q34115729-2F73A83B-B2D8-4B15-92C2-13944F3C2749

Q34115729-5D34BD15-2410-4856-A9F5-76345BDA4951

Q34115729-7BE41D59-2B46-4665-B8C2-4156B6555B7B

Q34115729-84E697C8-6FA6-4783-BA33-8ED1CA45A39F

Q34115729-9D902556-7735-426C-9AF6-EE5837F308D9

Q34115729-A94B81DE-EEAB-4A4B-8049-F68206D35777

Q34115729-BDB35BA6-4887-45EE-ADAB-DE5888BACFCE

Q34115729-FF7D42D5-B956-43E3-9A9E-52AB633E2EF6

P2860

Q34115729-0F5C149C-F1DF-4C53-A010-D1891BC08B2A

Q34115729-175C52B3-5972-4413-880F-F6C2C30275B1

Q34115729-1D135449-66CB-4CC9-906C-8DA70250DA08

Q34115729-1F2F1288-2E81-49B3-B486-DC991631A178

Q34115729-21689FEC-6DDC-4293-ACB5-C03BF7574CF4

Q34115729-220BC082-385D-48F1-AED0-D3AA1B92B77F

Q34115729-22118E0A-ADAD-4D19-863D-2BB698C6B5A7

Q34115729-27EB5C1D-C772-4AD5-B661-285D79336A8F

Q34115729-28875D88-3A46-4A49-9FB6-EA96F7FE2EBC

Q34115729-475C5BA1-ED33-4F29-AE16-3F86170DA080

P304

Q34115729-0A945460-C414-4C7E-AC4D-2303E19BB415

P31

Q34115729-EB99CE96-4CBD-4C76-BF1E-CE9E3A686971

P356

Q34115729-D1C6263F-38AC-40F3-A283-C76C0C6F6501

P407

Q34115729-3516C1DB-BB15-4922-AC52-A1ECC9098802

P433

Q34115729-6D5AAF4E-AD62-46C8-978D-DF7DF44C3B1E

P478

Q34115729-9809779E-AA41-4575-9033-BD9D44ED30A1

P577

Q34115729-2061CCA9-8BAE-4FC1-A445-D747A7BE2819

P698

Q34115729-A2A68988-0332-4C56-94D0-18C2C075218E

P921

Q34115729-ADAB0D95-E45C-46FD-A47E-7929C4A09C24

P932

Q34115729-2640D74F-CE7A-405B-9674-125F06A041C2

P356

J.SURG.2014.04.030

P1433

P1476

A principal component analysis ...... depletion versus fibrinolysis

@en

P2093

Angela Sauaia

http://www.w3.org/2001/XMLSchema#string

Anirban Banerjee

http://www.w3.org/2001/XMLSchema#string

Christopher R Ramos

http://www.w3.org/2001/XMLSchema#string

Eduardo Gonzalez

http://www.w3.org/2001/XMLSchema#string

Ernest E Moore

http://www.w3.org/2001/XMLSchema#string

Hunter B Moore

http://www.w3.org/2001/XMLSchema#string

John R Stringham

http://www.w3.org/2001/XMLSchema#string

Michael P Chapman

http://www.w3.org/2001/XMLSchema#string

Theresa L Chin

http://www.w3.org/2001/XMLSchema#string

P2860

Thrombocytopenia in critically ill surgical patients: a case-control study evaluating attributable mortality and transfusion requirements

Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial

Thrombocytopenia in septic shock patients--a prospective observational study of incidence, risk factors and correlation with clinical outcome.

Thrombocytopenia and outcome in critically ill patients with bloodstream infection.

Refractory postinjury thrombocytopenia is associated with multiple organ failure and adverse outcomes.

Thrombocytopenia in the pediatric burn patient.

Evaluation of the profile of thrombin generation during the process of whole blood clotting as assessed by thrombelastography

Human polymerized hemoglobin for the treatment of hemorrhagic shock when blood is unavailable: the USA multicenter trial.

Differentiation of enzymatic from platelet hypercoagulability using the novel thrombelastography parameter delta (delta)

Principal component analysis is a powerful instrument in occupational hygiene inquiries.

P304

570-577

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.SURG.2014.04.030

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

156

http://www.w3.org/2001/XMLSchema#string

P577

2014-06-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24962188

http://www.w3.org/2001/XMLSchema#string

P921

principal component analysis

P932

4150833

http://www.w3.org/2001/XMLSchema#string